Kiromic BioPharma, Inc.
KRBP · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26 | $43 | $90 | $117 |
| - Cash | $1 | $3 | $4 | $4 |
| + Debt | $15 | $15 | $13 | $14 |
| Enterprise Value | $39 | $55 | $100 | $127 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$6 | -$5 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$7 | -$7 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.31 | -4.59 | -4.71 |
| % Growth | 0% | 93.2% | 2.5% | – |
| Operating Cash Flow | -$4 | -$2 | -$8 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$2 | -$8 | -$6 |